Pharmacologic Therapies to Promote Recovery of Consciousness

Semin Neurol 2022; 42(03): 335-347
DOI: 10.1055/s-0042-1755271

Megan E. Barra

1   Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts

2   Department of Neurology, Center for Neurotechnology and Neurorecovery (CNTR), Massachusetts General Hospital, Boston, Massachusetts

,

Brian L. Edlow

2   Department of Neurology, Center for Neurotechnology and Neurorecovery (CNTR), Massachusetts General Hospital, Boston, Massachusetts

3   Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts

,

Gretchen M. Brophy

4   Department of Pharmacotherapy and Outcomes Science and Neurosurgery, Virginia Commonwealth University, Medical College of Virginia, Richmond, Virginia

› Author Affiliations Funding B.L.E. reports support from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (R21NS109627), and Tiny Blue Dot Foundation. B.L.E. and M.E.B. report support from the National Institutes of Health Director's Office (DP2HD101400) and James S. McDonnell Foundation. This work was completed at the time M.E.B. was employed with Massachusetts General Hospital; M.E.B. is now an employee of Marinus Pharmaceuticals.

留言 (0)

沒有登入
gif